SPDR S&P Pharmaceuticals ETF $XPH Shares Purchased by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. raised its holdings in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 6.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 171,930 shares of the company’s stock after purchasing an additional 10,842 shares during the period. Envestnet Portfolio Solutions Inc. owned about 4.65% of SPDR S&P Pharmaceuticals ETF worth $8,242,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in XPH. Park Avenue Securities LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the third quarter worth $485,000. U.S. Capital Wealth Advisors LLC grew its holdings in SPDR S&P Pharmaceuticals ETF by 2.6% during the 3rd quarter. U.S. Capital Wealth Advisors LLC now owns 14,730 shares of the company’s stock worth $706,000 after acquiring an additional 378 shares in the last quarter. Corient Private Wealth LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 2nd quarter worth about $294,000. EP Wealth Advisors LLC bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 2nd quarter worth about $278,000. Finally, SVB Wealth LLC raised its stake in shares of SPDR S&P Pharmaceuticals ETF by 24.5% in the 2nd quarter. SVB Wealth LLC now owns 41,012 shares of the company’s stock valued at $1,664,000 after purchasing an additional 8,079 shares in the last quarter.

SPDR S&P Pharmaceuticals ETF Stock Performance

Shares of XPH stock opened at $56.28 on Friday. SPDR S&P Pharmaceuticals ETF has a one year low of $35.22 and a one year high of $58.00. The company’s 50-day simple moving average is $55.38 and its 200-day simple moving average is $49.55. The stock has a market capitalization of $264.52 million, a price-to-earnings ratio of 14.28 and a beta of 0.60.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.